Neuromyelitis optica spectrum disorder presenting as rhomboencephalitis
Authors:
- 23 May 2018
- journal article
- case report
- Published by BMJ in BMJ Case Reports
- Vol. 2018
Abstract
Rhomboencephalitis, at least in its acute phase, is often a severely disabling syndrome, and can be life threatening. A range of underlying conditions can lead to this clinical syndrome. Rapid diagnosis to initiate treatment early is key to a beneficial outcome. We report the case of a 22 year old Afro-Caribbean woman, who presented with a two -week history of walking difficulties, upper limb incoordination and slurred speech. Her brainstem function deteriorated at pace, and she developed hypersomnia. A broad diagnostic approach led to prophylactic treatment for the most common infectious causes. This did not improve her symptoms. Non-infectious inflammatory causes were therefore considered and plasma exchange treatment was initiated leading to marked improvement within days. Screening for autoimmune conditions confirmed aquaporin-4 positive neuromyelitis optica spectrum disorder (NMOSD) as the underlying cause. Immunotherapy with rituximab was started. So far, no relapse has been observed. While the definition of NMOSD continues to be refined, aquaporin-4 testing should be considered early in patients presenting with rhomboencephalitis who do not respond to antibiotic and antiviral treatment. Vigilance and early intervention are key to limit morbidity and mortality from NMOSD.Keywords
This publication has 13 references indexed in Scilit:
- Rhombencephalitis: pictorial essayRadiologia Brasileira, 2016
- International consensus diagnostic criteria for neuromyelitis optica spectrum disordersNeurology, 2015
- MRI characteristics of neuromyelitis optica spectrum disorderNeurology, 2015
- Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patientsMultiple Sclerosis Journal, 2013
- Brain Involvement in Neuromyelitis Optica Spectrum DisordersArchives of Neurology, 2011
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximabNeurology, 2011
- Neuromyelitis Optica TreatmentArchives of Neurology, 2010
- IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channelJournal of Experimental Medicine, 2005
- Aquaporins and brain edemaSurgical Neurology, 2004
- The clinical course of neuromyelitis optica (Devic’s syndrome)Neurology, 1999